Personalized Risk-based Follow-up of Cervical Cancer Screening in Practice, RCT
Recruiting
N/A
Interventional Study
Cervical Cancer Screening
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 21 – 70
- Sex
- Female
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 7,500 (estimated)
- Sponsor
- Massachusetts General Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this PREDICT is to assess a personalize approach to screening and management of cervical cancer testing. The investigators will evaluate patients who are due for a follow up cervical cancer screening in the primary care clinics in the Massachusetts General Brigham system. Patients will be randomized by clinic into three different arms (Arm 1: standard care, Arm 2: visit based reminders…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria, Individuals who:
* have a cervix and are 21-70 years old
* receive care at a participating primary care practice (i.e. PCP team visit within past 3 years)
* have had a Pap and/ or HPV test within the past 3.5 years
* has a CCSM result that suggest a 5-year risk of developing CIN…
Contacts